Journal
EXPERIMENTAL CELL RESEARCH
Volume 280, Issue 2, Pages 192-200Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1006/excr.2002.5638
Keywords
opioid receptors; chemokine receptor; CCR5; oligomerization; immune cells
Categories
Funding
- NIDA NIH HHS [DA 10433, DA 05901] Funding Source: Medline
Ask authors/readers for more resources
Activation of opioid receptors by morphine was previously shown to specifically induce the expression of chemokine receptor CCR5, promoting simian AIDS virus entry and replication in immune cells. The present study was undertaken to determine whether these two structurally and functionally distinct G-protein-coupled receptors are in close proximity and form an oligomeric complex in the cell membrane so that the activation of one triggers the activity of the other. Both human CEM X 174 and monkey lymphocytes were used in this study and gave similar results. Immunoprecipitation experiments showed that CCR5, but not CD4 nor Na+/H+ exchanger, coprecipitates with all three subtypes (mu, delta, and kappa) of opioid receptors. A single protein band immunoreactive with antibodies against both the CCR5 and the opioid receptors was identified after electrophoresis on nondenaturing polyacrylamide gels. Chemical crosslinking experiments using glutaraldehyde or BS3 indicate that these receptors are closely situated on the cell membrane with an intermolecular distance less than 11.4Angstrom. Functional studies revealed that a combination treatment of cells with morphine, an agonist for mu, and MIP-1beta, a ligand for CCR5, suppresses the inhibitory effect of MIP-1beta and increases the stimulatory effect of morphine on CCR5 expression. These results suggest that oligomerization of chemokine receptor CCR5 and opioid receptors on the cell membrane of human or monkey lymphocytes may modulate receptor functions. (C) 2002 Elsevier Science (USA).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available